UK markets closed
NIKKEI 225
38,460.08 +907.92 (+2.42%) HANG SENG
17,201.27 +372.34 (+2.21%) CRUDE OIL
82.83 +0.02 (+0.02%) GOLD FUTURES
2,329.90 -8.50 (-0.36%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,611.62 -1,710.27 (-3.21%)
Adverum Biotechnologies, Inc. (ADVM)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 227.68M |
| Enterprise value | 206.19M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 30.72 |
| Price/book (mrq) | 2.73 |
| Enterprise value/revenue | 57.28 |
| Enterprise value/EBITDA | -1.74 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.79 |
| 52-week change 3 | 37.16% |
| S&P500 52-week change 3 | 25.01% |
| 52-week high 3 | 29.70 |
| 52-week low 3 | 7.10 |
| 50-day moving average 3 | 16.21 |
| 200-day moving average 3 | 13.88 |
Share statistics
| Avg vol (3-month) 3 | 283.58k |
| Avg vol (10-day) 3 | 174.66k |
| Shares outstanding 5 | 20.75M |
| Implied shares outstanding 6 | 20.75M |
| Float 8 | 11.72M |
| % held by insiders 1 | 0.91% |
| % held by institutions 1 | 81.80% |
| Shares short (28 Mar 2024) 4 | 889.95k |
| Short ratio (28 Mar 2024) 4 | 3.67 |
| Short % of float (28 Mar 2024) 4 | 4.46% |
| Short % of shares outstanding (28 Mar 2024) 4 | 4.29% |
| Shares short (prior month 29 Feb 2024) 4 | 542.55k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 21 Mar 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -3,437.97% |
Management effectiveness
| Return on assets (ttm) | -32.14% |
| Return on equity (ttm) | -88.43% |
Income statement
| Revenue (ttm) | 3.6M |
| Revenue per share (ttm) | 0.36 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -118.12M |
| Net income avi to common (ttm) | -117.17M |
| Diluted EPS (ttm) | -11.60 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 96.53M |
| Total cash per share (mrq) | 4.65 |
| Total debt (mrq) | 75.04M |
| Total debt/equity (mrq) | 89.90% |
| Current ratio (mrq) | 4.12 |
| Book value per share (mrq) | 8.23 |
Cash flow statement
| Operating cash flow (ttm) | -90.9M |
| Levered free cash flow (ttm) | -60.69M |
© 2024 Yahoo. All rights reserved.